Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer
ClinicalTrials.gov study NCT04494425. IPD Sharing: YES. Countries: 28. Publications: 2.
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
ClinicalTrials.gov study NCT01528345. IPD Sharing: Not stated. Countries: 15. Publications: 1.
A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer
ClinicalTrials.gov study NCT04288089. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Po
ClinicalTrials.gov study NCT03726879. IPD Sharing: YES. Countries: 12. Publications: 1.
PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors
ClinicalTrials.gov study NCT03284723. IPD Sharing: NO. Countries: 6. Publications: 1.
Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer
ClinicalTrials.gov study NCT01901146. IPD Sharing: Not stated. Countries: 18. Publications: 2.
Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00458237. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors
ClinicalTrials.gov study NCT02401347. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
ClinicalTrials.gov study NCT04639219. IPD Sharing: YES. Countries: 9. Publications: 2.
Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
ClinicalTrials.gov study NCT01522768. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Eribulin Mesylate With Trastuzumab for Advanced or Recurrent Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Breast Cancer
ClinicalTrials.gov study NCT01432886. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT01273610. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Cardiac Safety Study in Patients With HER2 + Breast Cancer
ClinicalTrials.gov study NCT01904903. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
ClinicalTrials.gov study NCT04579380. IPD Sharing: NO. Countries: 8. Publications: 2.
Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
ClinicalTrials.gov study NCT00303108. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00829166. IPD Sharing: Not stated. Countries: 27. Publications: 3.
Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.
ClinicalTrials.gov study NCT02789657. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal
ClinicalTrials.gov study NCT04661150. IPD Sharing: YES. Countries: 1. Publications: 2.
A Dose-Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Females
ClinicalTrials.gov study NCT00800436. IPD Sharing: Not stated. Countries: 2. Publications: 1.
DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease
ClinicalTrials.gov study NCT04420598. IPD Sharing: Not stated. Countries: 2. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.